trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'breast']
thrilled to have participated in this practice changing trial! #asco22 and now: trastuzumab deruxtecan in previously treated her2-low advanced breast cancer | nejm 